Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Hepatol. 2023 Jul 28;79(6):1408–1417. doi: 10.1016/j.jhep.2023.07.010

Table 3:

Rates of mortality while in hospital and at 30, 60, and 90-days by etiology of acute kidney injury

In Hospital 30-Day 60-Day 90-Day Sub-Hazard Ratio (95% CI) P value
Type of AKI
Prerenal AKI 6.1% 10.9% 18.6% 22.2% Reference ---
Hepatorenal syndrome 24.5% 36.1% 45.4% 49.0% 2.78 2.18–3.54) <0.001
Acute tubular necrosis 37.6% 40.9% 48.4% 52.7% 2.83 (2.36–3.41) <0.001
Other 6.5% 10.6% 20.3% 23.6% 1.04 (0.71–1.51) 0.85
Unable to classify 26.2% 33.6% 39.6% 45.0% 2.33 (1.75–3.09) <0.001
AKI Stage
Stage I 5.1% 11.0% 17.9% 21.7% Reference ---
Stage II 11.3% 18.9% 28.0% 31.6% 1.36 (1.08–1.71) 0.008
Stage III without renal replacement therapy 22.6% 32.3% 39.3% 43.7% 1.71 (1.38–2.13) <0.001
Stage III with renal replacement therapy 51.1% 46.5% 55.6% 59.6% 3.63 (2.86–4.61) <0.001
AKI Response
Complete response 2.2% 5.7% 13.1% 17.3% Reference ---
Partial response 11.3% 19.3% 29.3% 34.3% 2.04 (1.59–2.61) <0.001
No response 38.5% 44.7% 52.3% 55.6% 4.85 (4.03–5.84) <0.001
Transplant Listing Status
Listed for liver transplant 9.6% 8.5% 14.5% 16.7% Reference ---
Not listed for liver transplant 21.2% 27.7% 35.8% 40.1% 4.04 (3.00–5.45) <0.001

Key: AKI (acute kidney injury), HRS (hepatorenal syndrome), ATN (acute tubular necrosis). Absolute rates of death at in hospital, 30, 60, and 90 days represent unadjusted mortality rates at their respective intervals. Sub-Hazard ratios and P values are derived from multivariable models using Fine and Gray analysis for 90-day mortality, adjusted for age, race, gender, transplant listing status, center, and MELD-Na score.